ALISO VIEJO, Calif.--(BUSINESS WIRE)--ViaLase, Inc., a commercial stage medical technology company pioneering incision-free, laser-based solutions for glaucoma, today announced the successful completion of the first commercial FLIGHT procedures performed at Centre for Sight in London by Sheraz Daya, MD, and Gus Gazzard, MD, and at Breyer, Kaymak & Klabe Augenchirurgie in Düsseldorf, Germany, by Karsten Klabe, MD. The first commercial FLIGHT procedures were performed using the ViaLuxe® Laser Syst

Trop-2 H-scores Above 100 and PTEN H-scores Below 100 Correlated With Longer Progression Free Survival in Non-Small Cell Lung Cancer Patients Identified Biomarkers May Predict Patient Response, Enable Targeted Patient Selection and Allow for Precision Medicine AUSTIN, Texas, May 26, 2026 /PRNewswire/ -- Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today annou

Watkins-based Kazmira Therapeutics launches a first-of-its-kind telehealth platform for prescription cannabis. DENVER, May 26, 2026 /PRNewswire/ -- Kazmira Therapeutics, the company behind pioneering initiatives such as Kazmira Pharmacy and Cannabidiol API, today launched Cope Now, a novel telehealth platform to deliver a regulated clinical pathway for cannabidiol (CBD) care. The launch comes shortly after Kazmira's announcement of its prescription-only CBD pharmacy, the nation's first 503A phar

SK bioscience collaborates with Colombia's government-led US$260 million vaccine localization initiative through technology transfer and local manufacturing cooperation with state-owned pharmaceutical company VECOL This alliance enables SK bioscience to enter Latin America by manufacturing SKYVaricella, with potential expansion into a broader vaccine portfolio. SK–VECOL partnership establishes strategic foothold for broader LATAM expansion INCHEON, South Korea, May 26, 2026 /PRNewswire/ -- SK

Expansion driven by highly successful partnership based on Dario's consistent ability to engage members and deliver scalable value across cardiometabolic conditions NEW YORK, May 26, 2026 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO) (the "Company", "DarioHealth" or "Dario"), a leader in global digital health, today announced that its largest network partner to date, Solera Health, a leading digital health network connecting curated solutions to employers, health plans and other payers, has

BEIJING--(BUSINESS WIRE)--Biocytogen today announced the launch of RenSuper Workstation, a next-generation AI-powered antibody discovery platform providing off-the-shelf access to a large-scale, experimentally validated library of fully human therapeutic antibody sequences, together with the RenSuper High-Throughput Antibody Manufacturing Automation Center, a fully automated infrastructure designed to accelerate antibody validation and production. Built on Biocytogen’s proprietary RenMice® platf

NAARDEN, The Netherlands & WALTHAM, Mass.--(BUSINESS WIRE)--Prilenia Therapeutics B.V. today announced a Data Use Agreement (DUA) under which Prilenia will provide CHDI with clinical data from the placebo arms of its PRIDE and PROOF studies for the purpose of advancing research into treatments for Huntington's disease (HD). “Patients are at the center of this initiative; it is vital to foster an ecosystem where we can all work together to fully utilize high-quality data to enable future innovati

TORONTO, May 26, 2026 (GLOBE NEWSWIRE) -- Brain Cancer Canada (BCC), Canada’s only 100% volunteer-driven charity dedicated exclusively to funding brain cancer research nationwide is proud to award $50,000 to an exciting research project led by Dr Ian Lorimer and his team at Ottawa Hospital Research Institute (OHRI). The project titled “Improving glioblastoma immunotherapy by selectively blocking macrophage activity” explores a new way of possibly treating glioblastoma (GBM) and might soon pave

The new partnership brings together unified health data and clinical trial matching technology to reduce patient burden, improve enrollment efficiency, and help connect eligible patients to relevant clinical trial opportunities earlier in their care journey BALTIMORE, Md. and AMSTERDAM, May 26, 2026 /PRNewswire/ -- b.well Connected Health ("b.well"), the healthcare technology company unifying fragmented health data into AI-ready longitudinal records, and myTomorrows, a globally leading health te

Grant marks Alveo's entry into vaccine manufacturing market, extending its molecular detection platform beyond infectious disease diagnostics. ALAMEDA, Calif., May 26, 2026 /PRNewswire/ -- Alveo Technologies, Inc. (Alveo), a leader in portable molecular sensing solutions, today announced it has been awarded a grant from the Coalition for Epidemic Preparedness Innovations (CEPI) to explore how its platform, already in use around the globe for pathogen detection, can be used in vaccine manufactur